{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:20:27Z","timestamp":1782771627420,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Molecular events that drive disc damage and low back pain (LBP) may precede clinical manifestation of disease onset and can cause detrimental long-term effects such as disability. Biomarkers serve as objective molecular indicators of pathological processes. The goal of this study is to identify systemic biochemical factors as predictors of response to treatment of LBP with epidural steroid injection (ESI). Since inflammation plays a pivotal role in LBP, this pilot study investigates the effect of ESI on systemic levels of 48 inflammatory biochemical factors (cytokines, chemokines, and growth factors) and examines the relationship between biochemical factor levels and pain or disability in patients with disc herniation (DH), or other diagnoses (Other Dx) leading to low back pain, which included spinal stenosis (SS) and degenerative disc disease (DDD). Study participants (<jats:italic>n<\/jats:italic>\u00a0=\u00a016) were recruited from a back pain management practice. Pain numerical rating score (NRS), Oswestry Disability Index (ODI), and blood samples were collected pre- and at 7 to 10\u00a0days post-treatment. Blood samples were assayed for inflammatory mediators using commercial multiplex assays. Mediator levels were compared pre- and post-treatment to investigate the potential correlations between clinical and biochemical outcomes. Our results indicate that a single ESI significantly decreased systemic levels of SCGF-\u03b2 and IL-2. Improvement in pain in all subjects was correlated with changes in chemokines (MCP-1, MIG), hematopoietic progenitor factors (SCGF-\u03b2), and factors that participate in angiogenesis\/fibrosis (HGF), nociception (SCF, IFN-\u03b12), and inflammation (IL-6, IL-10, IL-18, TRAIL). Levels of biochemical mediators varied based on diagnosis of LBP, and changes in pain responses and systemic mediators from pre- to post-treatment were dependent on the diagnosis cohort. In the DH cohort, levels of IL-17 and VEGF significantly decreased post-treatment. In the Other Dx cohort, levels of IL-2R\u03b1, IL-3, and SCGF-\u03b2 significantly decreased post-treatment. In order to determine whether mediator changes were related to pain, correlations between change in pain scores and change in mediator levels were performed. Subjects with DH demonstrated a profile signature that implicated hematopoiesis factors (SCGF-\u03b2, GM-CSF) in pain response, while subjects with Other Dx demonstrated a biomarker profile that implicated chemokines (MCP-1, MIG) and angiogenic factors (HGF, VEGF) in pain response. Our findings provide evidence that systemic biochemical factors in patients with LBP vary by diagnosis, and pain response to treatment is associated with a unique profile of biochemical responses in each diagnosis group. Future hypothesis-based studies with larger subject cohorts are warranted to confirm the findings of this pilot exploratory study.<\/jats:p>","DOI":"10.1007\/s12026-015-8709-2","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T06:46:57Z","timestamp":1444114017000},"page":"170-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Exploratory study for identifying systemic biomarkers that correlate with pain response in patients with intervertebral disc disorders"],"prefix":"10.1007","volume":"63","author":[{"given":"K. T.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shina","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Olivier","family":"Alipui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Virojanapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheda","family":"Quraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ona","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeen O.","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"issue":"Suppl 2","key":"8709_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ner.12018","volume":"17","author":"L Manchikanti","year":"2014","unstructured":"Manchikanti L, et al. Epidemiology of low back pain in adults. Neuromodulation. 2014;17(Suppl 2):3\u201310.","journal-title":"Neuromodulation"},{"issue":"3","key":"8709_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/00007632-198704000-00013","volume":"12","author":"RA Deyo","year":"1987","unstructured":"Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine (Phila Pa 1976). 1987;12(3):264\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"7141","key":"8709_CR3","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/bmj.316.7141.1356","volume":"316","author":"PR Croft","year":"1998","unstructured":"Croft PR, et al. Outcome of low back pain in general practice: a prospective study. BMJ. 1998;316(7141):1356\u20139.","journal-title":"BMJ"},{"issue":"2","key":"8709_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0030-5898(20)31652-7","volume":"22","author":"JW Frymoyer","year":"1991","unstructured":"Frymoyer JW, Cats-Baril WL. An overview of the incidences and costs of low back pain. Orthop Clin North Am. 1991;22(2):263\u201371.","journal-title":"Orthop Clin North Am"},{"issue":"11","key":"8709_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/rheumatology\/kei028","volume":"44","author":"NK Arden","year":"2005","unstructured":"Arden NK, et al. A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. Rheumatology (Oxford). 2005;44(11):1399\u2013406.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8709_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.7326\/0003-4819-157-12-201212180-00564","volume":"157","author":"RZ Pinto","year":"2012","unstructured":"Pinto RZ, et al. Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis. Ann Intern Med. 2012;157(12):865\u201377.","journal-title":"Ann Intern Med"},{"key":"8709_CR7","doi-asserted-by":"publisher","first-page":"h1748","DOI":"10.1136\/bmj.h1748","volume":"350","author":"SP Cohen","year":"2015","unstructured":"Cohen SP, et al. Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study. BMJ. 2015;350:h1748.","journal-title":"BMJ"},{"issue":"2","key":"8709_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.spinee.2004.10.046","volume":"5","author":"RF McLain","year":"2005","unstructured":"McLain RF, Kapural L, Mekhail NA. Epidural steroid therapy for back and leg pain: mechanisms of action and efficacy. Spine J. 2005;5(2):191\u2013201.","journal-title":"Spine J"},{"key":"8709_CR9","doi-asserted-by":"crossref","unstructured":"Cannon DT, Aprill CN (2000), Lumbosacral epidural steroid injections. Arch Phys Med Rehabil, 81(3 Suppl 1): S87\u2013S98; quiz S99\u2013S100.","DOI":"10.1053\/apmr.2000.0810s87"},{"issue":"4","key":"8709_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S. Adjusting for multiple testing\u2014when and how? J Clin Epidemiol. 2001;54(4):343\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"8709_CR11","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.pmrj.2009.10.004","volume":"1","author":"KL Sainani","year":"2009","unstructured":"Sainani KL. The problem of multiple testing. PM R. 2009;1(12):1098\u2013103.","journal-title":"PM R"},{"issue":"8","key":"8709_CR12","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.apmr.2013.04.004","volume":"94","author":"A Stein","year":"2013","unstructured":"Stein A, et al. Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury. Arch Phys Med Rehabil. 2013;94(8):1498\u2013507.","journal-title":"Arch Phys Med Rehabil"},{"issue":"3 Pt 2","key":"8709_CR13","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1523\/JNEUROSCI.14-03-01433.1994","volume":"14","author":"JF Carnahan","year":"1994","unstructured":"Carnahan JF, Patel DR, Miller JA. Stem cell factor is a neurotrophic factor for neural crest-derived chick sensory neurons. J Neurosci. 1994;14(3 Pt 2):1433\u201340.","journal-title":"J Neurosci"},{"issue":"1","key":"8709_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1242\/dev.119.1.49","volume":"119","author":"T Hirata","year":"1993","unstructured":"Hirata T, et al. Stem cell factor induces outgrowth of c-kit-positive neurites and supports the survival of c-kit-positive neurons in dorsal root ganglia of mouse embryos. Development. 1993;119(1):49\u201356.","journal-title":"Development"},{"issue":"2","key":"8709_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0165-3806(94)00205-E","volume":"85","author":"T Hirata","year":"1995","unstructured":"Hirata T, et al. Characterization of c-kit-positive neurons in the dorsal root ganglion of mouse. Brain Res Dev Brain Res. 1995;85(2):201\u201311.","journal-title":"Brain Res Dev Brain Res"},{"issue":"4","key":"8709_CR16","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.neuroscience.2008.02.073","volume":"153","author":"K Takagi","year":"2008","unstructured":"Takagi K, et al. Involvement of stem cell factor and its receptor tyrosine kinase c-kit in pain regulation. Neuroscience. 2008;153(4):1278\u201388.","journal-title":"Neuroscience"},{"issue":"5","key":"8709_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neuron.2007.10.040","volume":"56","author":"N Milenkovic","year":"2007","unstructured":"Milenkovic N, et al. Nociceptive tuning by stem cell factor\/c-Kit signaling. Neuron. 2007;56(5):893\u2013906.","journal-title":"Neuron"},{"key":"8709_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2011.09.061","volume":"1442","author":"C Reyes-Vazquez","year":"2012","unstructured":"Reyes-Vazquez C, Prieto-Gomez B, Dafny N. Interferon modulates central nervous system function. Brain Res. 2012;1442:76\u201389.","journal-title":"Brain Res"},{"key":"8709_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000061055","volume":"29","author":"HO Besedovsky","year":"2002","unstructured":"Besedovsky HO, del Rey A. Introduction: immune-neuroendocrine network. Front Horm Res. 2002;29:1\u201314.","journal-title":"Front Horm Res"},{"issue":"3","key":"8709_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0197-0186(99)00124-2","volume":"36","author":"CL Jiang","year":"2000","unstructured":"Jiang CL, et al. Analgesic effect of interferon-alpha via mu opioid receptor in the rat. Neurochem Int. 2000;36(3):193\u20136.","journal-title":"Neurochem Int"},{"issue":"1\u20132","key":"8709_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0165-5728(00)00271-X","volume":"108","author":"YX Wang","year":"2000","unstructured":"Wang YX, et al. Distinct domains of IFNalpha mediate immune and analgesic effects respectively. J Neuroimmunol. 2000;108(1\u20132):64\u20137.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"8709_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neulet.2005.12.046","volume":"397","author":"JY Wang","year":"2006","unstructured":"Wang JY, et al. Mu- but not delta- and kappa-opioid receptor mediates the nucleus submedius interferon-alpha-evoked antinociception in the rat. Neurosci Lett. 2006;397(3):254\u20138.","journal-title":"Neurosci Lett"},{"issue":"3","key":"8709_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.spinee.2009.12.007","volume":"10","author":"JM Cuellar","year":"2010","unstructured":"Cuellar JM, et al. Cytokine evaluation in individuals with low back pain using discographic lavage. Spine J. 2010;10(3):212\u20138.","journal-title":"Spine J"},{"issue":"21","key":"8709_CR24","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1097\/BRS.0b013e3181af06b6","volume":"34","author":"GJ Scuderi","year":"2009","unstructured":"Scuderi GJ, et al. Epidural interferon gamma-immunoreactivity: a biomarker for lumbar nerve root irritation. Spine (Phila Pa 1976). 2009;34(21):2311\u20137.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"8709_CR25","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1213\/01.ane.0000275190.42912.37","volume":"105","author":"MA Thacker","year":"2007","unstructured":"Thacker MA, et al. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg. 2007;105(3):838\u201347.","journal-title":"Anesth Analg"},{"issue":"1","key":"8709_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrrheum.2013.160","volume":"10","author":"MV Risbud","year":"2014","unstructured":"Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44\u201356.","journal-title":"Nat Rev Rheumatol"},{"issue":"13","key":"8709_CR27","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/00007632-200207010-00006","volume":"27","author":"JG Burke","year":"2002","unstructured":"Burke JG, et al. Spontaneous production of monocyte chemoattractant protein-1 and interleukin-8 by the human lumbar intervertebral disc. Spine (Phila Pa 1976). 2002;27(13):1402\u20137.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"8709_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.yexmp.2014.12.002","volume":"98","author":"HE Gruber","year":"2015","unstructured":"Gruber HE, et al. Proinflammatory cytokines modulate the chemokine CCL2 (MCP-1) in human annulus cells in vitro: CCL2 expression and production. Exp Mol Pathol. 2015;98(1):102\u20135.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"8709_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1212\/WNL.0b013e31827b1aa1","volume":"80","author":"L Parkitny","year":"2013","unstructured":"Parkitny L, et al. Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology. 2013;80(1):106\u201317.","journal-title":"Neurology"},{"issue":"3","key":"8709_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/BSD.0b013e3181e15cc8","volume":"24","author":"C Romero-Sanchez","year":"2011","unstructured":"Romero-Sanchez C, et al. Serum monocyte chemotactic protein-1 concentrations distinguish patients with ankylosing spondylitis from patients with mechanical low back pain. J Spinal Disord Tech. 2011;24(3):202\u20137.","journal-title":"J Spinal Disord Tech"},{"issue":"3","key":"8709_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00007632-199602010-00003","volume":"21","author":"JD Kang","year":"1996","unstructured":"Kang JD, et al. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976). 1996;21(3):271\u20137.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"8","key":"8709_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/BRS.0b013e3181da38d5","volume":"36","author":"RK Studer","year":"2011","unstructured":"Studer RK, et al. Human nucleus pulposus cells react to IL-6: independent actions and amplification of response to IL-1 and TNF-alpha. Spine (Phila Pa 1976). 2011;36(8):593\u20139.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"12","key":"8709_CR33","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/BRS.0b013e3181e7f4a9","volume":"36","author":"Y Murata","year":"2011","unstructured":"Murata Y, et al. Local application of interleukin-6 to the dorsal root ganglion induces tumor necrosis factor-alpha in the dorsal root ganglion and results in apoptosis of the dorsal root ganglion cells. Spine (Phila Pa 1976). 2011;36(12):926\u201332.","journal-title":"Spine (Phila Pa 1976)"},{"key":"8709_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.expneurol.2012.12.007","volume":"241","author":"XH Wei","year":"2013","unstructured":"Wei XH, et al. The up-regulation of IL-6 in DRG and spinal dorsal horn contributes to neuropathic pain following L5 ventral root transection. Exp Neurol. 2013;241:159\u201368.","journal-title":"Exp Neurol"},{"key":"8709_CR35","doi-asserted-by":"crossref","unstructured":"Weber K, et al. (2015) Serum levels of the pro-Inflammatory cytokines IL-6 and TNF-alpha vary based on diagnoses in individuals with low back pain. Arthritis Res Ther (in review).","DOI":"10.1055\/s-0036-1582603"},{"key":"8709_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbi.2015.01.008","volume":"46","author":"LM Pedersen","year":"2015","unstructured":"Pedersen LM, et al. Serum levels of the pro-inflammatory interleukins 6 (IL-6) and -8 (IL-8) in patients with lumbar radicular pain due to disc herniation: A 12-month prospective study. Brain Behav Immun. 2015;46:132\u20136.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"8709_CR37","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/j.1532-2149.2014.502.x","volume":"18","author":"EI Schistad","year":"2014","unstructured":"Schistad EI, et al. Association between baseline IL-6 and 1-year recovery in lumbar radicular pain. Eur J Pain. 2014;18(10):1394\u2013401.","journal-title":"Eur J Pain"},{"issue":"11","key":"8709_CR38","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/jgs.13102","volume":"62","author":"GA Sowa","year":"2014","unstructured":"Sowa GA, et al. Associations between serum biomarkers and pain and pain-related function in older adults with low back pain: a pilot study. J Am Geriatr Soc. 2014;62(11):2047\u201355.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"8709_CR39","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.27444","volume":"62","author":"MF Shamji","year":"2010","unstructured":"Shamji MF, et al. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 2010;62(7):1974\u201382.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8709_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jor.21206","volume":"29","author":"MA Gabr","year":"2011","unstructured":"Gabr MA, et al. Interleukin-17 synergizes with IFNgamma or TNFalpha to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J Orthop Res. 2011;29(1):1\u20137.","journal-title":"J Orthop Res"},{"issue":"6","key":"8709_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3109\/10520295.2013.783235","volume":"88","author":"HE Gruber","year":"2013","unstructured":"Gruber HE, et al. Increased IL-17 expression in degenerated human discs and increased production in cultured annulus cells exposed to IL-1ss and TNF-alpha. Biotech Histochem. 2013;88(6):302\u201310.","journal-title":"Biotech Histochem"},{"issue":"1","key":"8709_CR42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3892\/etm.2015.2449","volume":"10","author":"P Tian","year":"2015","unstructured":"Tian P, et al. Role of interleukin-17 in chondrocytes of herniated intervertebral lumbar discs. Exp Ther Med. 2015;10(1):81\u20137.","journal-title":"Exp Ther Med"},{"issue":"1","key":"8709_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1313265","volume":"371","author":"JL Friedly","year":"2014","unstructured":"Friedly JL, et al. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med. 2014;371(1):11\u201321.","journal-title":"N Engl J Med"},{"key":"8709_CR44","first-page":"82","volume":"279","author":"KE Johnsson","year":"1992","unstructured":"Johnsson KE, Rosen I, Uden A. The natural course of lumbar spinal stenosis. Clin Orthop Relat Res. 1992;279:82\u20136.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"8709_CR45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3892\/mmr.2013.1450","volume":"8","author":"F Zou","year":"2013","unstructured":"Zou F, et al. Efficacy of intradiscal hepatocyte growth factor injection for the treatment of intervertebral disc degeneration. Mol Med Rep. 2013;8(1):118\u201322.","journal-title":"Mol Med Rep"},{"issue":"10","key":"8709_CR46","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2106\/JBJS.L.01790","volume":"96","author":"K Murakami","year":"2014","unstructured":"Murakami K, et al. Vein wrapping for chronic nerve constriction injury in a rat model: study showing increases in VEGF and HGF production and prevention of pain-associated behaviors and nerve damage. J Bone Joint Surg Am. 2014;96(10):859\u201367.","journal-title":"J Bone Joint Surg Am"},{"issue":"11","key":"8709_CR47","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1097\/01.ASN.0000141962.44300.3A","volume":"15","author":"R Gong","year":"2004","unstructured":"Gong R, et al. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. J Am Soc Nephrol. 2004;15(11):2868\u201381.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"8709_CR48","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jcp.22274","volume":"225","author":"P Bendinelli","year":"2010","unstructured":"Bendinelli P, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J Cell Physiol. 2010;225(3):757\u201366.","journal-title":"J Cell Physiol"},{"issue":"6","key":"8709_CR49","doi-asserted-by":"publisher","first-page":"e67303","DOI":"10.1371\/journal.pone.0067303","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, et al. HGF mediates the anti-inflammatory effects of PRP on injured tendons. PLoS ONE. 2013;8(6):e67303.","journal-title":"PLoS ONE"},{"issue":"6","key":"8709_CR50","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/mt.2013.69","volume":"21","author":"S Ajroud-Driss","year":"2013","unstructured":"Ajroud-Driss S, et al. Phase 1\/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy. Mol Ther. 2013;21(6):1279\u201386.","journal-title":"Mol Ther"},{"issue":"8","key":"8709_CR51","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/BRS.0b013e3181b9c986","volume":"35","author":"S Karamouzian","year":"2010","unstructured":"Karamouzian S, et al. Frequency of lumbar intervertebral disc calcification and angiogenesis, and their correlation with clinical, surgical, and magnetic resonance imaging findings. Spine (Phila Pa 1976). 2010;35(8):881\u20136.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1\u20132","key":"8709_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jneuroim.2008.01.005","volume":"195","author":"MM Backonja","year":"2008","unstructured":"Backonja MM, et al. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol. 2008;195(1\u20132):157\u201363.","journal-title":"J Neuroimmunol"},{"key":"8709_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jneuroim.2015.02.002","volume":"280","author":"E Kosek","year":"2015","unstructured":"Kosek E, et al. Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain\u2013interleukin-8 in fibromyalgia and interleukin-1 beta in rheumatoid arthritis. J Neuroimmunol. 2015;280:49\u201355.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"8709_CR54","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.gene.2013.05.069","volume":"527","author":"AS Lee","year":"2013","unstructured":"Lee AS, et al. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene. 2013;527(2):440\u20137.","journal-title":"Gene"},{"issue":"10","key":"8709_CR55","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.pain.2013.06.039","volume":"154","author":"M Lenz","year":"2013","unstructured":"Lenz M, et al. Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6\u00a0months. Pain. 2013;154(10):2142\u20139.","journal-title":"Pain"},{"issue":"31","key":"8709_CR56","doi-asserted-by":"publisher","first-page":"12728","DOI":"10.1073\/pnas.1118748109","volume":"109","author":"J Lampa","year":"2012","unstructured":"Lampa J, et al. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci USA. 2012;109(31):12728\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"8709_CR57","doi-asserted-by":"publisher","first-page":"e84159","DOI":"10.1371\/journal.pone.0084159","volume":"8","author":"M de Goeij","year":"2013","unstructured":"de Goeij M, et al. Systemic inflammation decreases pain threshold in humans in vivo. PLoS ONE. 2013;8(12):e84159.","journal-title":"PLoS ONE"},{"issue":"8","key":"8709_CR58","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K","volume":"28","author":"M Hurme","year":"1998","unstructured":"Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998;28(8):2598\u2013602.","journal-title":"Eur J Immunol"},{"issue":"4\u20135","key":"8709_CR59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","volume":"13","author":"WP Arend","year":"2002","unstructured":"Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002;13(4\u20135):323\u201340.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"8709_CR60","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.4238\/vol10-3gmr1283","volume":"10","author":"WP Lin","year":"2011","unstructured":"Lin WP, et al. Interleukin-10 promoter polymorphisms associated with susceptibility to lumbar disc degeneration in a Chinese cohort. Genet Mol Res. 2011;10(3):1719\u201327.","journal-title":"Genet Mol Res"},{"issue":"7","key":"8709_CR61","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nri2356","volume":"8","author":"JA Hamilton","year":"2008","unstructured":"Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol. 2008;8(7):533\u201344.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"8709_CR62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/ar318","volume":"3","author":"AD Cook","year":"2001","unstructured":"Cook AD, et al. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 2001;3(5):293\u20138.","journal-title":"Arthritis Res"},{"issue":"5","key":"8709_CR63","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1186\/ar4037","volume":"14","author":"AD Cook","year":"2012","unstructured":"Cook AD, et al. Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development. Arthritis Res Ther. 2012;14(5):R199.","journal-title":"Arthritis Res Ther"},{"key":"8709_CR64","doi-asserted-by":"crossref","unstructured":"Cuellar JM, et al. (2013) Does a fibronectin and aggrecan complex play a role in painful vertebral disks? PM R, 5(4): 297\u2013302; quiz 302.","DOI":"10.1016\/j.pmrj.2013.01.002"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-015-8709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-015-8709-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-015-8709-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-015-8709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T15:37:30Z","timestamp":1718120250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-015-8709-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":64,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8709"],"URL":"https:\/\/doi.org\/10.1007\/s12026-015-8709-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]},"assertion":[{"value":"6 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}